← Back to Search

Behavioral Intervention

Supportive-expressive group therapy (SEGT) for Amputation

N/A
Waitlist Available
Led By Rosalie Steinberg, MSC, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year.
Awards & highlights

Study Summary

This trial plans to test a new psychological group therapy program designed specifically for people with limb loss who are receiving inpatient rehabilitation. The goal is to see if the program can help improve mental health outcomes for this population.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants contacted for follow up interview
Participant recruitment
Participant retention
+2 more
Secondary outcome measures
Change in Body image
Change in Community participation
Change in Depression and Anxiety
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Supportive-expressive group therapyExperimental Treatment1 Intervention
The SEGT approach fosters mutual support, promotes openness and emotional expression. SEGT will be delivered and co-facilitated by a psychiatrist and an allied healthcare professional. It is a 6-module program held over a 3-week period (approximately 2 hour sessions X 2 week) that is framed within social cognitive theory, whereby resilience to adversity (limb loss in this instance) relies on personal enablement.
Group II: Treatment as usualActive Control1 Intervention
The treatment as usual group will receive standard care only (which may include an individual psychiatric consultation).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Supportive-expressive group therapy (SEGT)
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,550,597 Total Patients Enrolled
Rosalie Steinberg, MSC, MDPrincipal InvestigatorSunnybrook Health Sciences Centre

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have subscribed to this medical trial?

"Confirmed. According to the data on clinicaltrials.gov, this research is actively recruiting and has been since October 19th 2021. The last edit was done on September 29th 2022, with a goal of attaining 50 participants from 1 location."

Answered by AI

What is the purpose of this experiment?

"Over the duration of this trial, investigators will be monitoring one main outcome - the number of participants who are contacted for a follow-up interview. Additionally, they'll also assess changes in community participation (as measured by Reintegration to Normal Living Index), self-efficacy (via Coping Self-Efficacy Scale), and body image perception (through Amputee Body Image Scale-Revised)."

Answered by AI

Are there any open slots available in this clinical research?

"According to clinicaltrials.gov, this particular medical study is currently enrolling patients and has been since October 19th 2021. This information was last updated on September 29th 2022."

Answered by AI
Recent research and studies
Archives of Physical Medicine and RehabilitationJournal
Suicidal Ideation Among Individuals with Dysvascular Lower Extremity Amputation
Turner, Aaron P., Tiffany M. Meites, Rhonda M. Williams, Alison W. Henderson, Daniel C. Norvell, Kevin N. Hakimi, and Joseph M. Czerniecki. 2015. “Suicidal Ideation Among Individuals with Dysvascular Lower Extremity Amputation”. Archives of Physical Medicine and Rehabilitation. Elsevier BV. doi:10.1016/j.apmr.2015.04.001.
Journal of Rehabilitation MedicineJournal
Change in Health-related Quality of Life in the First 18 Months After Lower Limb Amputation: A Prospective, Longitudinal Study
Fortington, L, P Dijkstra, J Bosmans, W Post, and J Geertzen. 2013. “Change in Health-related Quality of Life in the First 18 Months After Lower Limb Amputation: A Prospective, Longitudinal Study”. Journal of Rehabilitation Medicine. Medical Journals Sweden AB. doi:10.2340/16501977-1146.
Disability and RehabilitationJournal
Understanding the Benefits of Prosthetic Prescription: Exploring the Experiences of Practitioners and Lower Limb Prosthetic Users
Schaffalitzky, Elisabeth, Pamela Gallagher, Malcolm Maclachlan, and Nicola Ryall. 2011. “Understanding the Benefits of Prosthetic Prescription: Exploring the Experiences of Practitioners and Lower Limb Prosthetic Users”. Disability and Rehabilitation. Informa UK Limited. doi:10.3109/09638288.2010.529234.
Health Promotion and Chronic Disease Prevention in CanadaJournal
The Cost of Diabetes in Canada over 10 Years: Applying Attributable Health Care Costs to a Diabetes Incidence Prediction Model
Bilandzic, Anja, and Laura Rosella. 2017. “The Cost of Diabetes in Canada over 10 Years: Applying Attributable Health Care Costs to a Diabetes Incidence Prediction Model”. Health Promotion and Chronic Disease Prevention in Canada. Health Promotion and Chronic Disease Prevention Branch (HPCDP) Public Health Agency of Canada. doi:10.24095/hpcdp.37.2.03.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top